Area of research
Psychiatry and Mental health · Pharmacology
Research interest
Research interests include Schizophrenia research and treatment, Cannabis and Cannabinoid Research, Child and Adolescent Psychosocial and Emotional Development, and Bipolar Disorder and Treatment.
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study
Adverse effects of heavy cannabis use: even plants can harm the brain
Psychometric properties of the dissociative symptoms scale (DSS) in Italian outpatients and community adults
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Cannabis Use and the Risk for Psychosis and Affective Disorders
Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use
Substance use, medication adherence and outcome one year following a first episode of psychosis
Interaction between cannabis consumption and childhood abuse in psychotic disorders: preliminary findings on the role of different patterns of cannabis use
Cannabis users have higher premorbid IQ than other patients with first onset psychosis